Association for University Centers on Disabilities (AUCD, Atlanta, Georgia, USA.
Genet Med. 2009 Dec;11(12):874-9. doi: 10.1097/GIM.0b013e3181c0c38d.
: There is limited information on long-term outcomes among children with Duarte galactosemia and controversy about treatment of this potentially benign condition. This study examined developmental disabilities and issues that required special education services within a population-based sample of children with Duarte galactosemia.
: Children born between 1988 and 2001 who were diagnosed with Duarte galactosemia and resided in the five-county metropolitan Atlanta area at birth and from 3 to 10 years of age were linked to the (1) Metropolitan Atlanta Developmental Disabilities Surveillance Program, an ongoing, population-based surveillance system for selected developmental disabilities and (2) Special Education Database of Metropolitan Atlanta. Special education records were reviewed for children who linked. Clinical genetics records were reviewed to assess laboratory levels at the time of diagnosis and metabolic control during treatment.
: Of the 59 eligible children, none were found to have intellectual disability, cerebral palsy, hearing loss, vision impairment, or an autism spectrum disorder. However, five, 8.5% of 3 to 10 years or 15.2% of eligible 8 years, were identified as having received special education services, four of whom were confirmed with a speech or language disorder, or were receiving services for speech or language or both compared with 4.5% and 5.9% of children without Duarte galactosemia, respectively.
: Despite galactose restriction until 1 year, select developmental issues associated with special education, specifically involving speech and language, have been found among some children with Duarte galactosemia.
关于杜阿尔特半乳糖血症患儿的长期预后资料有限,对于这种潜在良性疾病的治疗存在争议。本研究在基于人群的杜阿尔特半乳糖血症患儿样本中,调查了发育障碍以及需要特殊教育服务的问题。
1988 年至 2001 年间出生的、在诊断为杜阿尔特半乳糖血症时居住在亚特兰大都会区五个县内的儿童,以及在 3 至 10 岁时居住在亚特兰大都会区的儿童,与(1)亚特兰大都会发育障碍监测计划(一个正在进行的、针对特定发育障碍的基于人群的监测系统)和(2)亚特兰大都会特殊教育数据库相联系。对与系统联系的儿童进行特殊教育记录审查。查阅临床遗传学记录,评估诊断时的实验室水平和治疗期间的代谢控制情况。
在 59 名符合条件的儿童中,没有发现智力障碍、脑瘫、听力损失、视力障碍或自闭症谱系障碍。然而,5 名(3 至 10 岁的儿童中有 8.5%,8 岁时符合条件的儿童中有 15.2%)被确定为接受特殊教育服务,其中 4 名被确诊为言语或语言障碍,或正在接受言语或语言或两者的服务,而没有杜阿尔特半乳糖血症的儿童中分别为 4.5%和 5.9%。
尽管限制摄入半乳糖至 1 岁,但仍发现一些杜阿尔特半乳糖血症患儿存在与特殊教育相关的发育问题,特别是涉及言语和语言的问题。